|
1
|
Shi D, Liao N, Liu H, Gao W, Zhong S, Zheng C, Chen H, Xiao L, Zhu Y, Huang S, Zhang Y, Hu Y, Zheng Y, Ji J, Cheng J. Rapid Analysis of Compounds from Piperis Herba and Piperis Kadsurae Caulis and Their Differences Using High-Resolution Liquid-Mass Spectrometry and Molecular Network Binding Antioxidant Activity. Molecules 2024; 29:439. [PMID: 38257353 PMCID: PMC10821392 DOI: 10.3390/molecules29020439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2024] [Revised: 01/12/2024] [Accepted: 01/13/2024] [Indexed: 01/24/2024] Open
Abstract
There is a serious mixing of Piperis Herba and Piperis Kadsurae Caulis in various parts of China due to the similar traits of lianas, and there is a lack of systematic research on the compound and activity evaluation of the two. Likewise, the differences in compounds brought about by the distribution of origin also need to be investigated. In this study, high-resolution liquid-mass spectrometry (UPLC-Q-Zeno-TOF-MS/MS) was used to analyze samples of Piperis Herba from five origins and Piperis Kadsurae Caulis from five origins, with three batches collected from each origin. The compounds were identified based on precise molecular weights, secondary fragments, and an online database combined with node-to-node associations of the molecular network. The t-test was used to screen and analyze the differential compounds between the two. Finally, the preliminary evaluation of antioxidant activity of the two herbs was carried out using DPPH and ABTS free radical scavenging assays. The results showed that a total of 72 compounds were identified and deduced in the two Chinese medicines. These compounds included 54 amide alkaloids and 18 other compounds, such as flavonoid glycosides. The amide alkaloids among them were then classified, and the cleavage pathways in positive ion mode were summarized. Based on the p-value of the t-test, 32 differential compounds were screened out, and it was found that the compounds of Piperis Herba were richer and possessed a broader spectrum of antioxidant activity, thus realizing a multilevel distinction between Piperis Herba and Piperis Kadsurae Caulis. This study provides a preliminary reference for promoting standardization and comprehensive quality research of the resources of Piperis Herba using Piperis Kadsurae Caulis as a reference.
Collapse
Affiliation(s)
- Dezhi Shi
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; (D.S.); (N.L.); (H.L.); (W.G.); (S.Z.); (C.Z.); (H.C.); (L.X.); (Y.Z.); (S.H.); (Y.Z.); (Y.H.); (Y.Z.)
- Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing 210023, China
| | - Nanxi Liao
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; (D.S.); (N.L.); (H.L.); (W.G.); (S.Z.); (C.Z.); (H.C.); (L.X.); (Y.Z.); (S.H.); (Y.Z.); (Y.H.); (Y.Z.)
- Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing 210023, China
| | - Hualan Liu
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; (D.S.); (N.L.); (H.L.); (W.G.); (S.Z.); (C.Z.); (H.C.); (L.X.); (Y.Z.); (S.H.); (Y.Z.); (Y.H.); (Y.Z.)
- Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing 210023, China
| | - Wufeng Gao
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; (D.S.); (N.L.); (H.L.); (W.G.); (S.Z.); (C.Z.); (H.C.); (L.X.); (Y.Z.); (S.H.); (Y.Z.); (Y.H.); (Y.Z.)
- Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing 210023, China
| | - Shaohui Zhong
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; (D.S.); (N.L.); (H.L.); (W.G.); (S.Z.); (C.Z.); (H.C.); (L.X.); (Y.Z.); (S.H.); (Y.Z.); (Y.H.); (Y.Z.)
- Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing 210023, China
| | - Chao Zheng
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; (D.S.); (N.L.); (H.L.); (W.G.); (S.Z.); (C.Z.); (H.C.); (L.X.); (Y.Z.); (S.H.); (Y.Z.); (Y.H.); (Y.Z.)
- Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing 210023, China
| | - Haijie Chen
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; (D.S.); (N.L.); (H.L.); (W.G.); (S.Z.); (C.Z.); (H.C.); (L.X.); (Y.Z.); (S.H.); (Y.Z.); (Y.H.); (Y.Z.)
| | - Lianlian Xiao
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; (D.S.); (N.L.); (H.L.); (W.G.); (S.Z.); (C.Z.); (H.C.); (L.X.); (Y.Z.); (S.H.); (Y.Z.); (Y.H.); (Y.Z.)
- Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing 210023, China
| | - Yubo Zhu
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; (D.S.); (N.L.); (H.L.); (W.G.); (S.Z.); (C.Z.); (H.C.); (L.X.); (Y.Z.); (S.H.); (Y.Z.); (Y.H.); (Y.Z.)
- Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing 210023, China
| | - Shiwen Huang
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; (D.S.); (N.L.); (H.L.); (W.G.); (S.Z.); (C.Z.); (H.C.); (L.X.); (Y.Z.); (S.H.); (Y.Z.); (Y.H.); (Y.Z.)
| | - Yunyu Zhang
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; (D.S.); (N.L.); (H.L.); (W.G.); (S.Z.); (C.Z.); (H.C.); (L.X.); (Y.Z.); (S.H.); (Y.Z.); (Y.H.); (Y.Z.)
- Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing 210023, China
| | - Yang Hu
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; (D.S.); (N.L.); (H.L.); (W.G.); (S.Z.); (C.Z.); (H.C.); (L.X.); (Y.Z.); (S.H.); (Y.Z.); (Y.H.); (Y.Z.)
- Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing 210023, China
| | - Yunfeng Zheng
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; (D.S.); (N.L.); (H.L.); (W.G.); (S.Z.); (C.Z.); (H.C.); (L.X.); (Y.Z.); (S.H.); (Y.Z.); (Y.H.); (Y.Z.)
- Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing 210023, China
| | - Jing Ji
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; (D.S.); (N.L.); (H.L.); (W.G.); (S.Z.); (C.Z.); (H.C.); (L.X.); (Y.Z.); (S.H.); (Y.Z.); (Y.H.); (Y.Z.)
- Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing 210023, China
| | - Jianming Cheng
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; (D.S.); (N.L.); (H.L.); (W.G.); (S.Z.); (C.Z.); (H.C.); (L.X.); (Y.Z.); (S.H.); (Y.Z.); (Y.H.); (Y.Z.)
- Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing 210023, China
| |
Collapse
|
|
2
|
Li S, Feng G, Zhang M, Zhang X, Lu J, Feng C, Zhu F. Oxymatrine attenuates TNBS-induced colinutis in rats through TLR9/Myd88/NF-κB signal pathway. Hum Exp Toxicol 2022; 41:9603271221078866. [PMID: 35290143 DOI: 10.1177/09603271221078866] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Objective: Due to its well-known anti-inflammatory property, oxymatrine (OMT) has received more attention on the aspect of treating ulcerative colitis. Although efforts have been undertaken to understand the therapeutic mechanism of OMT on ulcerative colitis (UC), the remedial principle is still ambiguous. Numerous studies have shown that TLR9/Myd88/NF-κB signal pathway played a key role in the pathogenesis of UC. Moreover, TLR9/Myd88/NF-κB signal pathway is a part of the most important pathways for regulating the immune response.Methods: We explored the influence of OMT with different dosages on UC by establishing a 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis model. Moreover, the participation of TLR9/Myd88/NF-κB signal pathway and whether OMT protects against UC though targeting this pathway are further studied.Results: Our data revealed that OMT could significantly relieve the symptom of TNBS-induced colitis in rats by reactivating the tight junction protein and, more important, by inhibiting the activation of TLR9/Myd88/NF-κB pathway and protein expression levels of its downstream inflammatory factors.Conclusion: OMT could relieve colitis in rat models by impacting tight junction proteins' TLR9/Myd88/NF-κB signal pathways and activity.
Collapse
Affiliation(s)
- Shengwei Li
- Department of Anorectal, Yangzhou Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Yangzhou, China
| | - Guangqing Feng
- The Third Clinical Medicine College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China
| | - Min Zhang
- Department of Medical Oncology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China
| | - Xing Zhang
- The First Clinical Medicine College, Nanjing University of Chinese Medicine, Nanjing 210029, Jiangsu Province, China
| | - Jihong Lu
- Department of Anorectal, Yangzhou Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Yangzhou, China
| | - Chenyahui Feng
- Department of Anorectal, Yangzhou Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Yangzhou, China
| | - Fangshi Zhu
- The Third Clinical Medicine College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China
| |
Collapse
|
|
3
|
Hong Z, Tang P, Liu B, Ran C, Yuan C, Zhang Y, Lu Y, Duan X, Yang Y, Wu H. Ferroptosis-related Genes for Overall Survival Prediction in Patients with Colorectal Cancer can be Inhibited by Gallic acid. Int J Biol Sci 2021; 17:942-956. [PMID: 33867820 PMCID: PMC8040315 DOI: 10.7150/ijbs.57164] [Citation(s) in RCA: 44] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/25/2020] [Accepted: 02/15/2021] [Indexed: 01/19/2023] Open
Abstract
Colorectal cancer (CRC) is one of the most deadly malignant tumors, which seriously threatens human health. Ferroptosis, a new type of iron-dependent cell regulatory necrosis. Inducing ferroptosis of tumor cells is regarded as a potential treatment strategy. However, the prognostic value of ferroptosis-related genes in CRC remains to be further elucidated. Gallic acid, widely used in the chemical, pharmaceutical, and food fields, is a dietary supplement with potential prescription significance. In this study, the mRNA expression profiles and corresponding clinical data of CRC patients were downloaded from public databases. Gene Expression Profiling Interactive Analysis (GEPIA) was used to evaluate the expression levels of ferroptosis-related genes. In addition, bioinformatics analysis showed the prognostic value of ferroptosis-related genes in CRC. Molecular docking predicts the binding status of gallic acid and ferroptosis-related genes. The experiment confirmed the correctness of the predicted results. Our results show that in the TCGA cohort, 30 ferroptosis-related genes are differentially expressed between CRC and adjacent normal tissues. Among them, eight differentially expressed genes are related to overall survival. Gallic acid can bind to ferroptosis-related targets and regulate the expression of corresponding proteins, and ferroptosis inhibitors reversed the experimental results. In summary, eight new ferroptosis-related genes can be used to predict the prognosis of CRC. Gallic acid can improve CRC by regulating ferroptosis.
Collapse
Affiliation(s)
- Zongchao Hong
- Faculty of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China
| | - Peili Tang
- Faculty of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China
| | - Bo Liu
- Faculty of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China
| | - Chongwang Ran
- Faculty of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China
| | - Chong Yuan
- Faculty of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China
| | - Ying Zhang
- Faculty of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China
| | - Yi Lu
- Faculty of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China
| | - Xueyun Duan
- Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China
| | - Yanfang Yang
- Faculty of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China.,Key Laboratory of Traditional Chinese Medicine Resources and Chemistry of Hubei Province, Wuhan, China.,Collaborative Innovation Center of Traditional Chinese Medicine of New Products for Geriatrics Hubei Province, Wuhan, China
| | - Hezhen Wu
- Faculty of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China.,Key Laboratory of Traditional Chinese Medicine Resources and Chemistry of Hubei Province, Wuhan, China.,Collaborative Innovation Center of Traditional Chinese Medicine of New Products for Geriatrics Hubei Province, Wuhan, China
| |
Collapse
|